Introduction
160 mmol/l, creatinine clearance 60 ml/min). Laboratory investigation established the diagnosis of hypoHyperkalaemia is a potentially life-threatening electroreninaemic hypoaldosteronism secondary to chronic lyte abnormality. In normal subjects it is rare because interstitial nephritis of unknown origin. A lowthe homeostatic mechanisms to maintain normokalaepotassium diet plus small doses of frusemide were mia are highly effective. In particular, the capacity of introduced and the patient was discharged. A few days renal potassium excretion is very high under normal later he developed a urinary tract infection due to E circumstances [1] [2] [3] [4] . Consequently, hyperkalaemia is coli and co-trimoxazole in conventional doses (1600 mg practically always associated with impaired urinary of sulphamethoxazole+320 mg of trimethoprim) was potassium excretion [5] , but in patients with acute or administered. Five days later the patient was referred chronic renal failure high potassium intake can to our hospital with profound muscle weakness, further contribute to the development of hyperkalaenausea, and constipation. Laboratory investigation on mia ( Table 1) . the patient's admission showed severe hyperkalaemia We describe three cases of iatrogenic hyperkalaemia (serum potassium 7.8 mmol/l ) with ECG changes secondary to drug therapy. The cases illustrate the (peaked narrow T waves and a shortened QT interval ). wide spectrum of causes and preconditioning circumHyperkalaemia was accompanied by low potasstances. Based on these cases we discuss the appropriate sium excretion (urine potassium 19 mmol/l, FE K+ 9%, clinical management of this problem. TTKG 2.4). Additionally, a normal anion gap hyperchloraemic metabolic acidosis with an arterial pH of
Case report 1
7.29, a pCO 2 of 32 mmHg, a serum chloride level of 112 mmol/l, a serum bicarbonate of 15 mmol/l, a urine A 71-year-old man was admitted to our hospital anion gap of 23 mmol/l, and a urine pH of 5.1 was for evaluation of hyperkalaemia (serum potassium found. There was also evidence of a low urea excretion (FE urea 7.2%) in the face of the serum urea levels ( Table 2 ) and this is also illustrated by our patients [6] [7] [8] . It is of interest that typically the patients were brown, cloudy, and strongly positive for blood. The urinalysis contained scarce granular casts, 14-20 white elderly: In elderly subjects age-specific changes of renal function increase the risk of hyperkalaemia, particucells and 15-20 red cells per high-power field. Fibrate was discontinued, hyperkalaemia was properly treated, larly when other potassium-regulatory systems have been compromised [7, [9] [10] [11] [12] . and vigorous intravenous fluid therapy to correct the hypovolaemia was administered. Treatment was fol-
The first case illustrates that conventional doses of trimethoprim may cause hyperkalaemia when addilowed by a progressive decrease in serum creatinine, potassium and muscle enzymes towards normal tional predisposing conditions are present, i.e. in this case advanced age with hyporeninaemic hypoaldosvalues. On the patient's discharge 10 days later, muscle enzymes were normal, serum potassium was teronism [13] [14] [15] [16] . Trimethoprim inhibits amiloridesensitive sodium channels in the distal nephron and 4.5 mmol/l, serum creatinine 132 mmol/l, and creatinine clearance was 60 ml/min. dose-dependently reduces the transepithelial voltage which facilitates potassium secretion [17, 18] . It has been reported that even low doses of trimethoprim can
Case report 3
significantly decrease net transepithelial sodium transport and thus lower potassium excretion [18] . In socalled renal tubular acidosis type IV, associated with A 74-year-old patient was referred to our hospital with acute weakness, fatigue, flatulence and vomiting. He hyporeninaemic hypoaldosteronism and hyperkalaemia, tubular pH is typically low. This increases the was hypertensive and was receiving quinapril 20 mg once daily and a combination of frusemide plus amilor-concentration of the charged protonated species of trimethoprim, which blocks epithelial sodium channels ide (40 mg+5 mg) once daily. A mild impairment in renal function had been diagnosed (serum creatinine most effectively. Thus, the antikaliuretic effect of trimethoprim is further increased [19] . Finally, nausea, as 160 mmol/l ) 3 years before, as well as osteoporosis for which he was administered vitamin D and calcium. in our patient, reduces protein intake; low urea excretion (as documented by a low FE urea ) could have led Laboratory investigation on patient's admission revealed urea 71.4 mmol/l, creatinine 336 mmol/l, to a low flow rate and delivery of tubular fluid to the cortical collecting duct. This may have further contribglucose 9.2 mmol/l, sodium 130 mmol/l, potassium 8.2 mmol/l, calcium 2.7 mmol/l, phosphorus uted to a lower rate of potassium excretion in our patient and may have further exacerbated the impact 1.94 mmol/l, magnesium 0.9 mmol/l, chloride 106 mmol/l, bicarbonate 12 mmol/l, anion gap of trimethoprim-mediated blockage of sodium channels 12 mmol/l, arterial pH 7.30, and pCO 2 25 mmHg. Creatinine clearance was 20 ml/min. Urinalysis showed clinical manifestations of drug-induced hyperkalaemia.
aldosterone)
The incidence of this electrolyte abnormality has been Table 4 summarizes the great number of drugs with reports on drug-induced hyperkalaemia.
Beta-adrenergic antagonists may cause hyperkalaemia following a potassium load, severe exercise, on potassium excretion [20] . As to the management of such patients, it should be mentioned, that the antikali-or in the presence of hypoaldosteronism or renal failure [39] [40] [41] [42] . They alter transcellular partitioning of potasuretic effects of trimethoprim are minimized by raising urine pH [19] , as well as by manoeuvres that increase sium and reduce the activity of the renin-aldosterone system [5, 39] . Central adrenergic inhibitors, e.g. clonidistal delivery of sodium, e.g. administration of frusemide and of saline [21] .
dine, or beta-1-selective blockers, e.g. atenolol, interfere less with potassium homeostasis [43] [44] [45] . NonDrug-induced hyperkalaemia can also be caused by drug-induced rhabdomyolysis, as illustrated by the steroidal anti-inflammatory drugs lower plasma renin.
As a consequence, plasma potassium concentration second patient. Table 3 summarizes that, especially in the elderly patient [22, 23] , a number of drugs, alone rises moderately, by approximately 0.2 mmol/l in subjects with normal renal function, but may rise by more or in combination, can cause muscle damage, deterioration of renal function, and hyperkalaemia. Under than 1 mmol/l when renal function is impaired or when potassium homeostasis is strained, e.g. administration normal circumstances, the renal tubular cell will respond to an increase in serum potassium concentra-of potassium-sparing diuretics or non-cardioselective beta blockers [46] [47] [48] . Prolonged heparin administration by augmenting potassium secretion. If tissue destruction is intense, the ability of the kidney to tion may cause hyperkalaemia via inhibition of adrenal 18-hydroxylase [49] [50] [51] [52] [53] ; the risk of hyperkalaemia is excrete the potassium may be overwhelmed, so that hyperkalaemia ensues [24, 25] . The risk is further exacerbated by administration of ACE inhibitors or presence of long-standing diabetes mellitus [49, [52] [53] [54] [55] . aggravated, if rhabdomyolysis-induced renal failure occurs. In this circumstance, hyperkalaemia may An interesting condition, recently reported, is selective became life threatening. In our case, administration of ACE inhibitors and the resulting relative hypoaldos- Table 4 . Mechanisms of drug-induced hyperkalaemia teronism, may have also interfered with potassium excretion [26, 27] , illustrating that not infrequently predisposes to heparin-induced hyperkalaemia [12, 56 ] . 16. Williams GH. Hyporeninemic hypoaldosteronism. N Engl J Hyperkalaemia may also occur with low-molecular- 
